Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|July 11, 1991
A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infectionR T Davey, V J Davey, J A Metcalf, et al.
Annals of Internal Medicine|November 1, 1991
A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDSA G Palestine, M A Polis, M D De Smet, et al.
Blood|May 9, 2001
A potential role for interleukin-7 in T-cell homeostasisT J Fry, E Connick, J Falloon, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruriaM A Polis, K M Spooner, B F Baird, et al.
The New England Journal of Medicine|March 2, 1995
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary studyJ A Kovacs, M Baseler, R J Dewar, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 1999
JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1K Yoshimura, R Kato, K Yusa, et al.
The Journal of Infectious Diseases|March 14, 1998
Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoireJ C Gea-Banacloche, E E Weiskopf, C Hallahan, et al.
Pharmacotherapy|December 28, 1999
Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction studyJ Falloon, S Sargent, S C Piscitelli, et al.
The New England Journal of Medicine|October 31, 1996
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virusJ A Kovacs, S Vogel, J M Albert, et al.
AIDS (London, England)|September 14, 2000
Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppressionJ M Orenstein, N Bhat, C Yoder, et al.
Pageof 7